VRTX

Vertex Pharmaceuticals Incorporated (VRTX)

Last Price$409.9(0.5%)
Market Cap$105.0B
LTM Net Debt
($4,821.6M)
YoY Growth
-53.8%
3Y CAGR
-7.5%
5Y CAGR
+7.3%
Stock quality & Intrinsic value
6/10
13.5% overvalued

Vertex Pharmaceuticals Incorporated Net Debt

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Net Debt
($57.3M)
($361.2M)
($582.9M)
($440.9M)
($544.6M)
($1,131.1M)
($494.4M)
($513.0M)
($610.6M)
($958.5M)
($544.4M)
($216.2M)
($874.4M)
($1,459.7M)
($2,571.6M)
($3,146.6M)
($6,044.4M)
($6,557.5M)
($9,878.8M)
($10.4B)
VRTX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for VRTX and see if it's the right time to invest.
Dive in

Vertex Pharmaceuticals Incorporated (VRTX) Net Debt comparison analysis

Crunching data... Almost there!

VRTX key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Vertex Pharmaceuticals Incorporated's Net Debt?

As of today, Vertex Pharmaceuticals Incorporated's last 12-month Net Debt is ($4,821.6M), based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Vertex Pharmaceuticals Incorporated's Net Debt growth rate?

Over the last year, Vertex Pharmaceuticals Incorporated's Net Debt growth was (53.8%). The average annual Net Debt growth rates for Vertex Pharmaceuticals Incorporated have been (7.2%) over the past three years, 7.3% over the past five years.

3) Is Vertex Pharmaceuticals Incorporated's Net Debt growth rate Good?

Over the last year, Vertex Pharmaceuticals Incorporated's Net Debt growth was (53.8%), which is lower than industry growth of (0.1%). It indicates that Vertex Pharmaceuticals Incorporated's Net Debt growth is Good.

4) How does Vertex Pharmaceuticals Incorporated's Net Debt growth rate compare to its peers?

Over the last year, Vertex Pharmaceuticals Incorporated's Net Debt growth was (53.8%), which is lower than peer median growth of (45.7%). The list of peers includes MRNA, ALNY, BGNE, INCY, GMAB, NVO, UTHR, REGN, BNTX, ARGX etc.